Rab5a overexpression promoting ovarian cancer cell proliferation may be associated with APPL1-related epidermal growth factor signaling pathway

Cancer Science

Volumn 101, Issue 6, 2010, Pages 1454-1462

  Zhao, Zhen ^a   Liu, Xiang Fan ^a   Wu, Hua Cheng ^a   Zou, Shu Biao ^a   Wang, Jia Yi ^a   Ni, Pei Hua ^a   Chen, Xin Hua ^a   Fan, Qi Shi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR; PROTEIN APPL1; PROTEIN RAB5A; RAB PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE; CELL PROLIFERATION; CYCLIN D1; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RAB5 GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 77954169426     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01558.x     Document Type: Article

References (37)

1. Fujita M, Enomoto T, Murata Y. Genetic alterations in ovarian carcinoma: with specific reference to histological subtypes. Mol Cell Endocrinol 2003, 202:97-9.
2. Barnett GL, Friedrich CA. Recent developments in ovarian cancer genetics. Curr Opin Obstet Gynecol 2004, 16:79-85.
3. Schelling AN, Foulkes W. Molecular genetics of ovarian cancer. Mol Biotechnol 2001, 19:13-28.
4. Cheng KW, Lahad JP, Gray JW, Mills GB. Emerging role of RAB GTPases in cancer and human disease. Cancer Res 2005, 65:2516-9.
5. Bucci C, Chiariello M. Signal transduction gRABs attention. Cell Signal 2006, 18:1-8.
6. Su X, Kong C, Stahl PD. GAPex-5 mediates ubiquitination, trafficking, and degradation of epidermal growth factor receptor. J Biol Chem 2007, 282:21278-84.
7. Lanzetti L, Rybin V, Malabarba MG. The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. Nature 2000, 408:374-7.
8. Haas AK, Fuchs E, Kopajtich R, Barr FA. A GTPase-activating protein controls Rab5 function in endocytic trafficking. Nat Cell Biol 2005, 7:887-93.
9. Barbieri MA, Roberts RL, Gumusboga A. Epidermal growth factor and membrane trafficking: EGF receptor activation of endocytosis requires Rab5a. J Cell Biol 2000, 151:539-50.
10. Barbieri MA, Fernandez-Pol S, Hunker C, Horazdovsky BH, Stahl PD. Role of Rab5 in EGF receptor-mediated signal transduction. Eur J Cell Biol 2004, 83:305-14.
11. Martinu L, Santiago-Walker A, Qi H, Chou MM. Endocytosis of epidermal growth factor receptor regulated by Grb2-mediated recruitment of the Rab5 GTPase-activating protein RN-tre. J Biol Chem 2002, 277:50996-1002.
12. Saito T, Okada S, Ohshima K. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Endocrinology 2004, 145:4232-43.
13. Vieira AV, Lamaze C, Schmid SL. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 1996, 274:2086-9.
14. Grandal MV, Zandi R, Pedersen MW, Willumsen BM, van Deurs B, Poulsen HS. EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes. Carcinogenesis 2007, 28:1408-17.
15. Miaczynska M, Christoforidis S, Giner A. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 2004, 116:445-56.
16. Bucci C, Lütcke A, Steele-Mortimer O. Co-operative regulation of endocytosis by three Rab5 isoforms. FEBS Lett 1995, 366:65-71.
17. Chiariello M, Bruni CB, Bucci C. The small GTPases Rab5a, Rab5b and Rab5c are differentially phosphorylated in vitro. FEBS Lett 1999, 453:20-4.
18. Iyer VR, Eisen MB, Ross DT. The transcriptional program in the response of human fibroblasts to serum. Science 1999, 283:83-7.
19. Alvarez-Dominguez C, Stahl PD. Interferon-gamma selectively induces Rab5a synthesis and processing in mononuclear cells. J Biol Chem 1998, 273:33901-4.
20. Li Y, Meng X, Feng H, Zhang G, Liu C, Li P. Over-expression of the RAB5 gene in human lung adeno carcinoma cells with high metastatic potential. Chin Med Sci J 1999, 14:96-101.
21. Li Y, Feng H, Chen Y. Rab5a, a gene possibly related to metastasis of human carcinoma of the lung and stomach. Zhonghua Zhong Liu Za Zhi 1999, 21:178-81.
22. Fukui K, Tamura S, Wada A. Expression of Rab5a in hepatocellular carcinoma: possible involvement in epidermal growth factor signaling. Hepatology Research 2007, 37:957-65.
23. Tamaki K, Moriya T, Sato Y. Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis. Cancer Sci 2009, 100:88-94.
24. Song G, Cai QF, Mao YB, Ming YL, Bao SD, Ouyang GL. Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1a expression through the PI3-K/Akt pathway. Cancer Sci 2008, 99:1901-7.
25. Lin SY, Makino K, Xia W. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001, 3:802-8.
26. Horiuchi H, Lippé R, McBride HM. A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Cell 1997, 90:1149-59.
27. Banach-Orlowska M, Pilecka I, Torun A, Pyrzynska B, Miaczynska M. Functional characterization of the interactions between endosomal adaptor protein APPL1 and the NuRD co-repressor complex. Biochem J 2009, 423:389-400.
28. Maihle NJ, Baron AT, Barrette BA. EGF/ErbB receptor family in ovarian cancer. Cancer Treat Res 2002, 107:247-58.
29. Lassus H, Sihto H, Leminen A. Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma. J Mol Med 2006, 84:671-81.
30. Stadlmann S, Gueth U, Reiser U. Epithelial growth factor receptor status in primary and recurrent ovarian cancer. Mod Pathol 2006, 19:607-10.
31. Santiskulvong C, Sinnett-Smith J, Rozengurt E. EGF receptor function is required in late G(1) for cell cycle progression induced by bombesin and bradykinin. Am J Physiol Cell Physiol 2001, 281:C886-98.
32. Miettinen P, Ormio P, Hakonen E, Banerjee M, Otonkoski T. EGF receptor in pancreatic beta-cell mass regulation. Biochem Soc Trans 2008, 36:280-5.
33. Fili Nn, Calleja V, Woscholski R, Parker PJ, Larijani B. Compartmental signal modulation: endosomal phosphatidylinositol 3-phosphate controls endosome morphology and selective cargo sorting. PNAS 2006, 103:15473-8.
34. Lagger G, O'Carroll D, Rembold M. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J 2002, 21:2672-81.
35. Manavathi B, Kumar R. Metastasis tumor antigens, an emerging family of multifaceted master coregulators. J Biol Chem 2007, 282:1529-33.
36. Cunliffe VT. Eloquent silence: developmental functions of class I histone deacetylases. Curr Opin Genet Dev 2008, 18:404-10.
37. McDonel P, Costello I, Hendrich B. Keeping things quiet: roles of NuRD and Sin3 co-repressor complexes during mammalian development. Int J Biochem Cell Biol 2009, 41:108-16.